+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Teva Pharmaceutical Industries Ltd (TEVA) - Financial and Strategic SWOT Analysis Review

Teva Pharmaceutical Industries Ltd (TEVA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by the publisher to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Teva Pharmaceutical Industries Ltd (Teva) discovers, develops, manufactures, and commercializes generic and specialty medicines. The company provides specialty medicines to treat disorders of the central nervous system (CNS), cancer, respiratory, dermatology, women’s health, and other disease conditions. It offers generic medicines in a range of dosage forms including capsules, tablets, injectables, liquids, inhalants, creams, and ointments. Teva also provides over-the-counter (OTC) products, besides active pharmaceutical ingredients (APIs). It focuses on developing new generic drugs. The company conducts its worldwide operations through a network of subsidiaries in regions such as North America, Europe, and International Markets. Teva is headquartered in Tel Aviv, Israel.

Teva Pharmaceutical Industries Ltd Key Recent Developments

  • Mar 16, 2023: ART MEDICAL announces partnership with Teva Israel to bring its lifesaving technology to critical care units
  • Feb 08, 2023: Teva Reports Fourth Quarter and Full Year 2022 Financial Results
  • Jan 19, 2023: Teva’s ambitious climate targets externally validated by the Science Based Targets initiative (SBTi)
  • Jan 12, 2023: Teva to Host Conference Call to Discuss Fourth Quarter and Full Year 2022 Financial Results and 2023 Financial Guidance at 8 a.m. ET on February 8, 2023

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Section 1 - About the Company
  • Teva Pharmaceutical Industries Ltd - Key Facts
  • Teva Pharmaceutical Industries Ltd - Key Employees
  • Teva Pharmaceutical Industries Ltd - Key Employee Biographies
  • Teva Pharmaceutical Industries Ltd - Major Products and Services
  • Teva Pharmaceutical Industries Ltd - History
  • Teva Pharmaceutical Industries Ltd - Company Statement
  • Teva Pharmaceutical Industries Ltd - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
  • Joint Venture
Section 2 - Company Analysis
  • Company Overview
  • Teva Pharmaceutical Industries Ltd - Business Description
  • Geographical Segment: Europe
  • Target Markets
  • Performance
  • Overview
  • Geographical Segment: International Markets
  • Target Markets
  • Performance
  • Geographical Segment: North America
  • Target Markets
  • Performance
  • Overview
  • Geographical Segment: Other Activities
  • Performance
  • Overview
  • R&D Overview
  • Teva Pharmaceutical Industries Ltd - Corporate Strategy
  • Teva Pharmaceutical Industries Ltd - SWOT Analysis
  • SWOT Analysis - Overview
  • Teva Pharmaceutical Industries Ltd - Strengths
  • Teva Pharmaceutical Industries Ltd - Weaknesses
  • Teva Pharmaceutical Industries Ltd - Opportunities
  • Teva Pharmaceutical Industries Ltd - Threats
  • Teva Pharmaceutical Industries Ltd - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • Teva Pharmaceutical Industries Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
  • Teva Pharmaceutical Industries Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2017 to YTD 2023
  • Teva Pharmaceutical Industries Ltd, Recent Deals Summary
Section 5 - Company’s Recent Developments
  • Mar 16, 2023: ART MEDICAL announces partnership with Teva Israel to bring its lifesaving technology to critical care units
  • Feb 08, 2023: Teva Reports Fourth Quarter and Full Year 2022 Financial Results
  • Jan 19, 2023: Teva’s ambitious climate targets externally validated by the Science Based Targets initiative (SBTi)
  • Jan 12, 2023: Teva to Host Conference Call to Discuss Fourth Quarter and Full Year 2022 Financial Results and 2023 Financial Guidance at 8 a.m. ET on February 8, 2023
  • Jan 09, 2023: Teva announces nationwide opioids settlement to move forward after receiving broad support from states
  • Nov 22, 2022: Teva Finalizes Nationwide Opioid Settlement Terms
  • Nov 21, 2022: Teva Announces Appointment of Richard Francis as President and CEO
  • Nov 03, 2022: Teva Reports Third Quarter 2022 Financial Results
  • Oct 07, 2022: Teva reaches agreement with Arkansas to settle the state’s price fixing claims
  • Sep 30, 2022: Teva reaches agreement with Georgia to settle the state’s price fixing claims
Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About the Publisher
  • Contact the Publisher
  • Disclaimer
List of Tables
  • Teva Pharmaceutical Industries Ltd, Key Facts
  • Teva Pharmaceutical Industries Ltd, Key Employees
  • Teva Pharmaceutical Industries Ltd, Key Employee Biographies
  • Teva Pharmaceutical Industries Ltd, Major Products and Services
  • Teva Pharmaceutical Industries Ltd, History
  • Teva Pharmaceutical Industries Ltd, Subsidiaries
  • Teva Pharmaceutical Industries Ltd, Joint Venture
  • Teva Pharmaceutical Industries Ltd, Key Competitors
  • Teva Pharmaceutical Industries Ltd, Ratios based on current share price
  • Teva Pharmaceutical Industries Ltd, Annual Ratios
  • Teva Pharmaceutical Industries Ltd, Interim Ratios
  • Teva Pharmaceutical Industries Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
  • Teva Pharmaceutical Industries Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2017 to YTD 2023
  • Teva Pharmaceutical Industries Ltd, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Teva Pharmaceutical Industries Ltd, Performance Chart (2018 - 2022)
  • Teva Pharmaceutical Industries Ltd, Ratio Charts
  • Teva Pharmaceutical Industries Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
  • Teva Pharmaceutical Industries Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2017 to YTD 2023

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Mapi Pharma Ltd
  • Mallinckrodt Plc
  • Bristol-Myers Squibb Co
  • Sandoz Inc
  • AstraZeneca Plc
  • Pfizer Inc
  • MediciNova Inc
  • Momenta Pharmaceuticals Inc
  • Merck & Co Inc
  • Teligent Inc
  • GSK plc
  • BiondVax Pharmaceuticals Ltd
  • Apotex Inc
  • Antares Pharma Inc
  • Allergan Ltd
  • Chiesi Farmaceutici SpA
  • Amgen Inc
  • Mapi Pharma Ltd
  • Mallinckrodt Plc
  • Bristol-Myers Squibb Co
  • Momenta Pharmaceuticals Inc
  • Merck & Co Inc
  • GSK plc
  • Pfizer Inc
  • MediciNova Inc
  • Chiesi Farmaceutici SpA
  • Amgen Inc
  • Antares Pharma Inc
  • Allergan Ltd
  • Teligent Inc
  • BiondVax Pharmaceuticals Ltd
  • Sandoz Inc
  • AstraZeneca Plc
  • Apotex Inc